The Food and Drug Administration (Thai FDA) held a bilateral meeting with representatives from the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan to exchange regulatory information on the oversight of pharmaceuticals and medical devices, with particular emphasis on Advanced Therapy Medicinal Products (ATMPs), clinical research, and the expansion of academic and regulatory cooperation across Asia.

Ms. Supattra Boonserm, Secretary-General of the Thai Food and Drug Administration, welcomed Dr. Naoyuki Yasuda, Chief Secretary (International Programs) to the PMDA Chief Executive, together with Dr. Shinichi Noda, Head of the PMDA Asia Office, and the PMDA delegation during their visit to the Thai FDA. The meeting focused on strengthening regulatory cooperation between Thailand and Japan in the field of medical products.

On this occasion, Secretary-General also congratulated Dr. Shinichi Noda on his appointment as Head of the PMDA Asia Office in April 2026 and expressed confidence that his leadership would further enhance regulatory collaboration throughout the Asian region. The Secretary-General stated that the Thai FDA highly values its longstanding partnership with PMDA, covering pharmaceutical and medical device regulation, capacity building, and the promotion of international regulatory harmonization. These collaborative efforts contribute to improving public access to quality, safe, and effective medical products. During the meeting, both sides exchanged views on regulatory approaches for Advanced Therapy Medicinal Products (ATMPs), clinical research, and opportunities to further expand academic and technical collaboration across Asia. The discussions reaffirmed the shared commitment of both regulatory authorities to strengthening regulatory systems and promoting innovation while ensuring the continued protection of public health.